Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGCG for Taxane-Induced Peripheral Neuropathy
NCT06524609Phase 2Recruiting
- Start
- Nov 2023
- Primary completion
- Nov 2024
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epigallocatechin gallate in chemotherapy-induced peripheral neuropathy (CIPN). Started Nov 2023; status: recruiting.
02
Drugs
epigallocatechin gallate
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT06524609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06524609.